Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-kappa B signaling pathway

文献类型： 外文期刊

第一作者： Hu, Yue

作者： Hu, Yue;Wu, Xiangju;Zhao, Xiaomin;Wang, Jinbao;Hu, Yue;Cong, Xiaoyan;Chen, Lei;Qi, Jing;Wu, Xiangju;Zhou, Mingming;Sun, Wenbo;Wu, Jiaqiang;Chen, Zhi;Yu, Jiang;Du, Yijun;Wang, Jinbao;Yoo, Dongwan;Li, Feng

作者机构：

期刊名称：SCIENTIFIC REPORTS （ 影响因子：4.379； 五年影响因子：5.133 ）

ISSN： 2045-2322

年卷期： 2016 年 6 卷

页码：

收录情况： SCI

摘要： PRRS is one of the most important diseases in swine industry. Current PRRS inactivated vaccine provides only a limited protection and cannot induce sufficient cell-mediated immune responses. In this study, we first found that the mRNA and protein levels of Th1-type cytokines (IFN-gamma, IL-12) and Th2-type cytokines (IL-6, IL-10) were significantly increased through TRIF/MyD88-NF-kappa B signaling pathway when porcine peripheral blood monocyte-derived dendritic cells (MoDCs) were treated with poly (I: C) of TLR3 ligand and imiquimod of TLR7 ligand, along with inactivated PRRSV antigen. Meanwhile, the ability of catching PRRSV antigen was also significantly enhanced. In mice experiment, it was found that the PRRSV-specific T lymphocyte proliferation, the percentages of CD4(+), CD8(+) T lymphocytes and PRRSV-specific CD3(+) T cells producing IFN-gamma and IL-4, the levels of Th1- and Th2-type cytokines and the titers of neutralization antibody were significantly enhanced in poly (I: C), imiquimod along with inactivated PRRSV group. Taken together, results of our experiments described for the first time that synergy of TLR3 and 7 ligands could significantly enhance the function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-kappa B signaling pathway and be used as adjuvant candidate for the development of novel PRRS inactivated vaccine.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序